Results
eNauka >
Results >
IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC
| Title: | IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC | Authors: | Spigel, D; ...; Andric, Zoran G   ; ...; (broj, koautora 20) |
Issue Date: | 2019 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 30 str. 915-915 | WoS-ID: | 000491295500202 | URI: | https://enauka.gov.rs/handle/123456789/811871 | Project: | F. Hoffmann-La RocheHoffmann-La Roche | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
74
WEB OF SCIENCETM
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.